Op-Ed | New York needs to get THC beverages right | amNewYork

THC-infused beverages represent a rapidly expanding cannabis product category in states like New York where recreational use is legal, introducing new considerations for clinicians counseling patients about cannabis consumption. Unlike traditional smoked or edible cannabis products, beverages present distinct pharmacokinetic profiles, dosing consistency challenges, and packaging concerns that affect both therapeutic efficacy and safety. The growing popularity of THC drinks among consumers, particularly younger populations unfamiliar with cannabis effects, increases the clinical relevance of understanding absorption rates, onset of action, and the potential for accidental overdose or misuse compared to more conventional cannabis forms. Regulatory frameworks governing THC beverage potency, labeling, and marketing will directly influence the risk profile patients encounter and the information available to guide clinical counseling. Clinicians should familiarize themselves with the specific characteristics of THC beverages, including their variable absorption and delayed peak effects, to provide informed guidance on dosing, timing of consumption, and potential drug interactions. Clear understanding of how THC beverages compare to other cannabis delivery methods will help clinicians better counsel patients on safe and effective use for both medical and recreational purposes.

💬 Join the Conversation

Have a question about how this applies to your situation?
Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers?
Join the forum discussion →

Have thoughts on this? Share it: